Thymosin β15 expression in tumor cell lines with varying metastatic potential

Clinical and Experimental Metastasis

Volumn 16, Issue 3, 1998, Pages 227-233

  Bao, Lere ^a   Loda, Massimo ^b   Zetter, Bruce R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Carcinomas; Gene expression; Metastasis; Thymosin 15

Indexed keywords

MESSENGER RNA; THYMOSIN; RNA; THYMOSIN BETA(15);

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROSTATE CARCINOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; ANIMAL; CELL CULTURE; ENZYME IMMUNOASSAY; GENETICS; LUNG TUMOR; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

ANIMALS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MICE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RATS; RNA, MESSENGER; RNA, NEOPLASM; THYMOSIN; TUMOR CELLS, CULTURED;

EID: 0031596754     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006540824969     Document Type: Article

References (25)

1. Fidler IJ, Gersten DM and Hart IR, 1978, The biology of cancer invasion and metastasis. Adv Cancer Res, 28, 149-250.
2. Liotta LA and Kohn E, 1988, Tumor invasion and metastasis: biochemical mechanisms. Treatment Res Cancer, 40, 223-38.
3. Nicolson GL, 1988, Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta, 948, 175-224.
4. Zetter BR, 1990, The cellular basis of site-specific tumor metastasis. N Engl J Med, 322, 605-12.
5. Hosaka S, Suzuki M, Goto M and Sato H, 1978, Motility of rat ascites hepatoma cells, with reference to malignant characteristics in cancer metastasis. Gann, 69, 273-6.
6. Haemmerlin G and Strauli P, 1981, In vitro motility of cells from human epidermoid carcinoma: a study by phase-contrast and reflection-contrast cinematography. Int J Cancer, 27, 603-10.
7. Mohler JL, Partin AW and Coffey DS, 1988, Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model. Cancer Res, 48, 4312-17.
8. Partin AW, Schoeniger JS, Mohler JL and Coffey DS, 1989, Fourier analysis of cell motility; correlation of motility with metastatic potential. Proc Natl Acad Sci USA, 86, 1254-8.
9. Mohler JL, 1993, Cellular motility and prostatic carcinoma metastases. Cancer Metast Rev, 12, 53-67.
10. Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B and Zetter BR, 1996, Thymosin β15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nature Med, 2, 1322-8.
11. Mihelic M and Voelter W, 1994, Distribution and biological activity of β-thymosins. Amino Acids, 6, 1-13.
12. Low TLK, Hu SK and Goldstein AL, 1981, Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci USA, 78, 1162-6.
13. Cassimeris L, Saler D, Nachmias VT and Zigmond SH, 1992, Thymosin sequesters the majority of G-actin in resting human polymorphonuclear leukocytes. J Cell Biol, 119, 1261-70.
14. Yu F-X, Lin SC, Morrison-Bogorad M and Yin HL, 1993, Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem, 268, 502-9.
15. Isaacs JT, Isaacs WB, Feitz WFJ and Scheres J, 1986, Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostate cancers. Prostate, 9, 261-81.
16. Freeman MR, Bagli DJ, Lamb CC, et al. 1994, Culture of a prostatic cell line in basement membrane gels results in an enhancement of malignant properties and constitutive alterations in gene expression. J Cell Physiol, 158, 325-36.
17. Brodt P, 1986, Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities. Cancer Res, 46, 2442-8.
18. Wang M and Stearms ME, 1991, Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice. Differentiation, 48, 115-25.
19. Bao L, Matsumura D, Baban D, Sun Y and Tarin D, 1994, Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells. Br J Cancer, 70, 228-32.
20. Chomczynski P and Sacchi N, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 167, 157-9.
21. Gomez-Marquez J, Dosil M, Segade F, et al. 1989, Thymosin-β4 gene: preliminary characterization and expression in tissues, thymic cells, and lymphocytes. J Immunol, 143, 2740-4.
22. Lin S and Morrison-Bogorad M, 1990, Developmental expression of mRNAs encoding thymosin β4 and β10 in rat brain and other tissues. J Mol Neurosci, 2, 35-44.
23. Yu F-X, Lin SC, Morrison-Bogorad M and Yin HL, 1993, Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem, 268, 502-9.
24. Hall A, 1991, Differential expression of thymosin genes in human tumours and in the developing human kidney. Int J Cancer, 48, 672-7.
25. Hug C, Jay PY, Reddy I, et al. 1995, Capping protein levels influence actin assembly and cell motility in Dictyostelium. Cell, 81, 591-600.